Brief report: identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by whole-exome sequencing

Simple item page
dc.contributor.authorEllyard, J.
dc.contributor.authorJerjen, R.
dc.contributor.authorMartin, J.
dc.contributor.authorLee, A.
dc.contributor.authorField, M.
dc.contributor.authorJiang, S.
dc.contributor.authorCappello, J.
dc.contributor.authorNaumann, S.
dc.contributor.authorAndrews, T.
dc.contributor.authorScott, H.
dc.contributor.authorCasarotto, M.
dc.contributor.authorGoodnow, C.
dc.contributor.authorChaitow, J.
dc.contributor.authorPascual, V.
dc.contributor.authorHertzog, P.
dc.contributor.authorAlexander, S.
dc.contributor.authorCook, M.
dc.contributor.authorVinuesa, C.
dc.date.issued2014
dc.description.abstractObjective: Systemic lupus erythematosus (SLE) isa chronic and heterogeneous autoimmune disease. Both twin and sibling studies indicate a strong genetic contribution to lupus, but in the majority of cases the pathogenic variant remains to be identified. The genetic contribution to disease is likely to be greatest in cases with early onset and severe phenotypes. Whole-exome sequencing now offers the possibility of identifying rare alleles responsible for disease in such cases. This study was undertaken to identify genetic causes of SLE using whole-exome sequencing. Methods: We performed whole-exome sequencing in a 4-year-old girl with early-onset SLE and conducted biochemical analysis of the putative defect. Results: Whole-exome sequencing in a 4-year-old girl with cerebral lupus identified a rare, homozygous mutation in the three prime repair exonuclease 1 gene(TREX1) that was predicted to be highly deleterious. The TREX1 R97H mutant protein had a 20-fold reduction in exonuclease activity and was associated with an elevated interferon-alpha signature in the patient. The discovery and characterization of a pathogenic TREX1 variant in our proband has therapeutic implications. The patient is now a candidate for therapy. Conclusion: Our study is the first to demonstrate that whole-exome sequencing can be used to identify rare or novel deleterious variants as genetic causes of SLE and, through a personalized approach, improve therapeutic options.
dc.description.statementofresponsibilityJulia I. Ellyard, Rebekka Jerjen, Jaime L. Martin, Adrian Y. S. Lee, Matthew A. Field, Simon H. Jiang, Jean Cappello, Svenja K. Naumann, T. Daniel Andrews, Hamish S. Scott, Marco G. Casarotto, Christopher C. Goodnow, Jeffrey Chaitow, Virginia Pascual, Paul Hertzog, Stephen I. Alexander, Matthew C. Cook, and Carola G. Vinuesa
dc.identifier.citationArthritis & Rheumatology, 2014; 66(12):3382-3386
dc.identifier.doi10.1002/art.38824
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.orcidScott, H. [0000-0002-5813-631X]
dc.identifier.urihttp://hdl.handle.net/2440/99505
dc.language.isoen
dc.publisherWiley
dc.rights© 2014, American College of Rheumatology
dc.source.urihttps://doi.org/10.1002/art.38824
dc.subjectSystemic lupus erythematosus (SLE)
dc.titleBrief report: identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by whole-exome sequencing
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications